The changing face of childhood nephrotic syndrome.
Chesney
Russell
R
Department of Pediatrics, LeBonheur Children's Medical Center, and the University of Tennessee College of Medicine, Memphis, Tennessee 38103, USA. rchesney@utmem.edu
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002648:Child; D005260:Female; D005923:Glomerulosclerosis, Focal Segmental / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D008775:Methylprednisolone / Q000627:therapeutic use; D009404:Nephrotic Syndrome / Q000188:drug therapy / Q000473:pathology* / Q000503:physiopathology*; D011507:Proteinuria / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology; D000077583:Quinapril; D044005:Tetrahydroisoquinolines / Q000627:therapeutic use
D000806:Angiotensin-Converting Enzyme Inhibitors; D000893:Anti-Inflammatory Agents; D044005:Tetrahydroisoquinolines; D000077583:Quinapril; D008775:Methylprednisolone